Where Will Loblaw Stock Be in 1/3/5 Years?
Let's dive into the near- and medium-term outlook for Loblaw (TSX:L) stock and where experts see this company headed from here.
Act Now to Get $45 Off Your New Costco Membership
Want a Costco membership for only $1.67 a month? Find out how Costco's limited-time new membership deal can dramatically cut ...
The Maravi Post23h
Chakwera for good tobacco prices
KASUNGU-(MANA)-President Lazarus Chakwera on Monday said his government will identify more leaf buyers to ensure there are competitive prices that can benefit farmers, in the 2024/2025 market season.
insurancebusinessmag3d
Beneva's drug strategy yields $71 million in savings
Alongside biosimilars, Beneva has forged product listing agreements that offer a 12% average discount on more than 50 ...
I’m a pharmacist — the best value medications at Dollar Tree, including a $1.25 ‘lifetime supply’ gel
Generally, he added, the best value you’ll find are creams, and he’s a fan of Dollar Tree’s CareAll brand arthritis and ...
Food prices worried most voters, but Trump's plans likely won't lower their grocery bills
Americans are fed up with the price of food, and many are looking to President-elect Donald Trump to lower their grocery ...
Vancouver Is Awesome5d
Loblaw ramps up efforts to capture more customers as it reports profit up in Q3
Loblaw had a busy third quarter as it ramped up efforts to capture more deal-seeking shoppers, pharmacy customers and ...
Loblaw to cut food prices at Shoppers Drug Mart as customers pull back
Including those and other adjustments in the same quarter the previous year, adjusted net earnings available to common ...
API prices expected to stabilise by Q4FY25, says Akums Drugs’ Maheshwari
API prices have been under pressure over the past few quarters due to weak demand and competition from China in export ...
CTV News9d
COVID-19 vaccine supply gaps expected to ease in Sask.
Saskatchewan is expecting a new shipment of updated COVID-19 vaccines next week, after a supply hiccup meant some couldn’t ...
Ozempic’s maker wants the US government to ban cheaper versions of the high-priced $969 injection weight-loss drug – claims the formula is ‘too complex’ to cop…
Critics, including Senator Bernie Sanders, question whether the push to block alternatives is truly about safety — or simply ...
Xebra Brands Executes First Distribution Agreement
VANCOUVER, BC / ACCESSWIRE / November 7, 2024 / Xebra Brands ('Xebra' or the 'Company') (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a leading player in the Mexican CBD industry, is pleased to announce the ...